000 | 01849 a2200553 4500 | ||
---|---|---|---|
005 | 20250515091818.0 | ||
264 | 0 | _c20080116 | |
008 | 200801s 0 0 eng d | ||
022 | _a0893-228X | ||
024 | 7 |
_a10.1021/tx700170q _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaniels, J Scott | |
245 | 0 | 0 |
_aSpecies-specific, P450- and sulfotransferase-mediated novel ring contraction of a naphthyridine-N-oxide compound in cynomolgus monkey. _h[electronic resource] |
260 |
_bChemical research in toxicology _cNov 2007 |
||
300 |
_a1709-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-HIV Agents _xchemistry |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCyclic N-Oxides _xchemistry |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xphysiology |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aHIV Reverse Transcriptase _xantagonists & inhibitors |
650 | 0 | 4 |
_aHepatocytes _xmetabolism |
650 | 0 | 4 | _aMacaca fascicularis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrosomes, Liver _xmetabolism |
650 | 0 | 4 |
_aNaphthyridines _xchemistry |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xchemistry |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 |
_aSulfotransferases _xphysiology |
700 | 1 | _aEspina, Robert | |
700 | 1 | _aCao, Kevin | |
700 | 1 | _aYuan, Haodan | |
700 | 1 | _aLin, Jianrong | |
700 | 1 | _aDiamond, Sharon | |
700 | 1 | _aJohnson, Barry | |
700 | 1 | _aRodgers, James | |
700 | 1 | _aPrakash, Shimoga | |
700 | 1 | _aUnger, Steve | |
700 | 1 | _aChrist, David | |
700 | 1 | _aMiwa, Gerald | |
700 | 1 | _aGan, Liang-Shang | |
700 | 1 | _aMutlib, Abdul | |
773 | 0 |
_tChemical research in toxicology _gvol. 20 _gno. 11 _gp. 1709-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/tx700170q _zAvailable from publisher's website |
999 |
_c17460140 _d17460140 |